Endocrine effects of adjuvant chemotherapy in premenopausal women: suggestions for the future.
Tormey
D C
DC
Department of Human Oncology, University of Wisconsin, Madison 53792.
D000568:Amenorrhea / Q000453:epidemiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008593:Menopause / Q000187:drug effects; D015201:Meta-Analysis as Topic; D008727:Methotrexate / Q000008:administration & dosage; D013629:Tamoxifen / Q000627:therapeutic use*
D013629:Tamoxifen; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate